vs
Side-by-side financial comparison of Cellyan Biotechnology Co., Ltd (HKPD) and NU SKIN ENTERPRISES, INC. (NUS). Click either name above to swap in a different company.
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
Revenue
HKPD
NUS
| Q4 25 | — | $370.3M | ||
| Q3 25 | — | $364.2M | ||
| Q2 25 | — | $386.1M | ||
| Q1 25 | — | $364.5M | ||
| Q4 24 | — | $445.6M | ||
| Q3 24 | — | $430.1M | ||
| Q2 24 | — | $439.1M | ||
| Q1 24 | — | $417.3M |
Net ProfitHKPDNUS
| Q4 25 | — | $14.5M | ||
| Q3 25 | — | $17.1M | ||
| Q2 25 | — | $21.1M | ||
| Q1 25 | — | $107.5M | ||
| Q4 24 | — | $-36.1M | ||
| Q3 24 | — | $8.3M | ||
| Q2 24 | — | $-118.3M | ||
| Q1 24 | — | $-533.0K |
Gross MarginHKPDNUS
| Q4 25 | — | 70.7% | ||
| Q3 25 | — | 70.5% | ||
| Q2 25 | — | 68.8% | ||
| Q1 25 | — | 67.8% | ||
| Q4 24 | — | 62.7% | ||
| Q3 24 | — | 70.1% | ||
| Q2 24 | — | 70.0% | ||
| Q1 24 | — | 70.5% |
Operating MarginHKPDNUS
| Q4 25 | — | 6.3% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | — | -2.7% | ||
| Q4 24 | — | -11.9% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | — | -28.6% | ||
| Q1 24 | — | 2.1% |
Net MarginHKPDNUS
| Q4 25 | — | 3.9% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 29.5% | ||
| Q4 24 | — | -8.1% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | -26.9% | ||
| Q1 24 | — | -0.1% |
EPS (diluted)HKPDNUS
| Q4 25 | — | $0.27 | ||
| Q3 25 | — | $0.34 | ||
| Q2 25 | — | $0.43 | ||
| Q1 25 | — | $2.14 | ||
| Q4 24 | — | $-0.73 | ||
| Q3 24 | — | $0.17 | ||
| Q2 24 | — | $-2.38 | ||
| Q1 24 | — | $-0.01 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
